MORE►
biotech
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
by Lance Murray |
Apr 8, 2025
With the new funding, Caris said it has raised $1.86 billion in capital since 2018. Caris will use the raise to bring its science and technologies "to as many patients as possible and further our goal of revolutionizing precision medicine," Founder and CEO David Halbert said.
MORE►
by Quincy Preston |
Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species.
Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
MORE►
by Nicole Ward, DRC Data Journalist |
Mar 27, 2025
Eido Bio’s three co-founders are taking on menopause, research gaps, and a market where women’s health “sort of starts and stops with birth control.” The biotech startup is raising a Series A to launch clinical trials for a menopause treatment—and help shift the science toward women.
MORE►
[Photo: Elayne Massaini/istockphoto]
Muscling Up Dogs: Westlake-Based Virbac NA Launches Soft Chews That Improve Canine Mobility
by Lance Murray | Jan 9, 2025
Virbac said that URSOLYX Soft Chews target mRNA expression in skeletal muscle, harnessing the proven benefits of ursolic acid to enhance muscle function and strength in aging, active, or recovering dogs.
MORE►
by Glenn Hunter |
Oct 24, 2024
Fundraising has slowed and valuations are down, but biotech founders could have a lifeline in family office investments, panelists at the recent BioNTX summit in Arlington agreed. They said succeeding with these investors can take time, a lot of education, and a compelling, well-crafted story that connects emotionally with the family.
MORE►
by Nicole Ward, DRC Data Journalist |
Aug 14, 2024
Carter Inc. aims to be the first call for both corporate and high-stakes biotech relocations, working to keep transitions smooth and operations on track.
MORE►
by Nicole Ward, DRC Data Journalist |
Jul 25, 2024
Verily, Alphabet's health tech subsidiary, is shifting its headquarters to Dallas-Fort Worth's Cypress Waters development, positioning the Google sister company at the heart of a growing healthcare and tech ecosystem.
MORE►
Kansas City Chiefs Chairman and Chief Executive Officer Clark Hunt (left) and Dallas Mavericks legend and NBA champion Dirk Nowitzki will headline the Venture Dallas Summit on October 25. The sports icons will open and close the event focused on innovation, technology, and entrepreneurship. [Photo: Venture Dallas]
‘Conversations With Champions’: Sports Titans Hunt, Nowitzki to Headline Venture Dallas Summit
by Quincy Preston | Oct 16, 2023
The NFL and NBA icons—Clark Hunt and Dirk Nowitzki—will kick off and wrap up discussions on innovation and investment. They add to an "impressive speaker lineup" including Nextdoor Co-Founder Nirav Tolia and other trailblazing speakers. Here's the full roster.
MORE►
by Lance Murray |
Oct 6, 2023
It's national pasta month. The Texas mother, author, and philanthropist—married to Matthew McConaughey—has partnered with the Dallas-connected "better-for-you" pasta brand launched by Arcadia Biosciences. To entice families, it offers a "clean-plate guarantee."
MORE►
by Quincy Preston |
Sep 27, 2023
The rebrand "marks the start of our next chapter of growth," says Venture Dallas Chair Aaron Pierce. The nonprofit's 2023 summit, backed by JPMorgan Chase and Perot Jain, is set for October 25.
MORE►
by Quincy Preston and Lance Murray |
Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
No Sugar-Coating: Vertex Pharma Founder Shares 8 ‘Rules’ for Startup Success
by Quincy Preston | Jul 26, 2023
From an old car parts garage, Vertex Founder Joshua Boger launched the Boston-based biotech giant in 1989, running it for two decades as CEO. Boger "unretired" in June to join fast-moving Alkeus Pharmaceuticals as executive chairman.
In Dallas, he shared the "mistakes" that led to his success with innovators at Pegasus Park. Here's his no-holds-barred dose of truth for all entrepreneurs.
In Dallas, he shared the "mistakes" that led to his success with innovators at Pegasus Park. Here's his no-holds-barred dose of truth for all entrepreneurs.
MORE►
by Quincy Preston |
Jul 18, 2023
Parker Health's cloud Health Management System is the first in the U.S. to build on the Fast Healthcare Interoperability Resources—or FHIR—standard to create an interoperable, affordable, and compliant cloud-based platform. The Parker Suite aims to unify patient-centric data, biometrics, diagnostic tools, patient outcomes, care delivery, practitioner engagement, and pharmaceuticals for the healthcare ecosystem.
MORE►
by Nicole Ward, DRC Data Journalist |
Jun 8, 2023
Elina Lavit, originally from the Soviet Union, charted a new course in 2021. Swapping San Francisco for Dallas, she's now steering business development at OncoNano Medicine, a North Texas biotech that aims to revolutionize cancer treatment.
MORE►
by Lance Murray |
Jun 6, 2023
VanTrust Real Estate, which has an office in Dallas, has announced a new division that is designed to match its real estate expertise and capital resources with both public and private sector clients in the life sciences, R&D, institutional, governmental, biotech, pharmaceutical and technology industries....
MORE►
